SPDR S&P Biotech ETF $XBI Shares Acquired by Trek Financial LLC

Trek Financial LLC lifted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 105.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 80,717 shares of the exchange traded fund’s stock after purchasing an additional 41,441 shares during the quarter. Trek Financial LLC’s holdings in SPDR S&P Biotech ETF were worth $12,727,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in XBI. Ayalon Insurance Comp Ltd. boosted its position in shares of SPDR S&P Biotech ETF by 71.9% during the 3rd quarter. Ayalon Insurance Comp Ltd. now owns 95,600 shares of the exchange traded fund’s stock worth $15,074,000 after acquiring an additional 40,000 shares in the last quarter. Wellington Management Group LLP acquired a new position in SPDR S&P Biotech ETF during the second quarter valued at approximately $19,270,000. TD Waterhouse Canada Inc. lifted its stake in SPDR S&P Biotech ETF by 535.1% during the second quarter. TD Waterhouse Canada Inc. now owns 5,265 shares of the exchange traded fund’s stock worth $824,000 after purchasing an additional 4,436 shares during the last quarter. Syon Capital LLC lifted its stake in SPDR S&P Biotech ETF by 67.9% during the second quarter. Syon Capital LLC now owns 23,562 shares of the exchange traded fund’s stock worth $3,729,000 after purchasing an additional 9,530 shares during the last quarter. Finally, Maven Securities LTD bought a new stake in SPDR S&P Biotech ETF during the second quarter worth $3,028,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $155.98 on Monday. SPDR S&P Biotech ETF has a 52-week low of $106.30 and a 52-week high of $169.89. The firm has a market cap of $10.72 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. The business’s fifty day moving average is $156.60 and its 200-day moving average is $141.58.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.